Search company, investor...

Stage

Acquired | Acquired

Total Raised

$2.5M

Valuation

$0000 

About Allon Therapeutics

Allon Therapeutics Inc. is a clinical-stage biotechnology company developing treatments for major neurodegenerative conditions. Allon has 3 Phase II human efficacy trials underway pursuing three large underserved markets: Alzheimer's disease, schizophrenia and cognitive impairment.

Headquarters Location

1168 Hamilton Street Suite 506

Vancouver, British Columbia, V6B 2S2,

Canada

Loading...

Loading...

Allon Therapeutics Patents

Allon Therapeutics has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/18/2010

12/4/2012

Autoimmune diseases, Proteins, Transcription factors, Piperidines, Syndromes

Grant

Application Date

2/18/2010

Grant Date

12/4/2012

Title

Related Topics

Autoimmune diseases, Proteins, Transcription factors, Piperidines, Syndromes

Status

Grant

Latest Allon Therapeutics News

Allon Therapeutics Frequently Asked Questions (FAQ)

  • Where is Allon Therapeutics's headquarters?

    Allon Therapeutics's headquarters is located at 1168 Hamilton Street, Vancouver.

  • What is Allon Therapeutics's latest funding round?

    Allon Therapeutics's latest funding round is Acquired.

  • How much did Allon Therapeutics raise?

    Allon Therapeutics raised a total of $2.5M.

  • Who are the investors of Allon Therapeutics?

    Investors of Allon Therapeutics include Allon Therapeutics, Linkagene, NDI Capital and BC Advantage Funds.

  • Who are Allon Therapeutics's competitors?

    Competitors of Allon Therapeutics include Intercept Pharmaceuticals, Intarcia Therapeutics, Rhythm Pharmaceuticals, Vistagen, Pulmatrix and 7 more.

Loading...

Compare Allon Therapeutics to Competitors

I
Intarcia Therapeutics

Intarcia Therapeutics operates as a biopharmaceutical company. The company develops and commercializes therapies to transform the prevention and management of chronic diseases. The company was founded in 1995 and is based in Boston, Massachusetts.

I
Inagen Aps

Inagen was formed in 2007 to develop therapies for viral diseases. The company's primary candidate is treatment for Cytomegalovirus (CMV). There is a great unmet need for effective treatment to eradicate this serious disease.

A
Aderis Pharmaceuticals

Aderis Pharmaceuticals, formerly Discovery Therapeutics, develops and commercializes small molecule, receptor-specific therapeutics for the treatment of central nervous system, cardiovascular and renal diseases.

T
Tacere Therapeutics

Tacere Therapeutics is a biotechnology company focused on the development of novel therapeutics for serious infectious diseases. The company specializes in RNA interference (RNAi) technology to create treatments that target and silence specific genes associated with the progression of diseases such as Hepatitis C (HCV). It was founded in 2006 and is based in San Jose, California.

M
Metabolic Solutions Development

Metabolic Solutions Development is a drug discovery and development company focused on creating novel therapeutics for metabolic diseases. Their main products are therapeutic drugs designed to modulate mitochondrial function and address insulin resistance and type 2 diabetes. The company primarily serves the healthcare sector, particularly in the field of metabolic and age-related diseases. It was founded in 2006 and is based in Kalamazoo, Michigan.

I
Intercept Pharmaceuticals

Intercept Pharmaceuticals engages in the development and commercialization of novel therapeutics in the healthcare sector. Its offerings include the development and delivery of medicines for conditions such as primary biliary cholangitis and severe alcohol-associated hepatitis. The company primarily serves the healthcare industry, with a particular emphasis on liver health. It was founded in 2002 and is based in Morristown, New Jersey.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.